Close Menu

NEW YORK (GenomeWeb) – Diagnostics firm Applied Proteomics has sold substantially all of its assets to biotech startup DiscernDx for $1.85 million.

The sale marks the end for the San Diego-based proteomics firm, which was launched in 2007 by David Agus, director of the University of Southern California's Center for Applied Molecular Medicine, and Danny Hillis, chairman and cofounder of technology firm Applied Minds.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.